CAS 89365-50-4
:Salmeterol
Description:
Salmeterol is a long-acting beta-2 adrenergic agonist primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). It functions by stimulating beta-2 adrenergic receptors in the smooth muscle of the airways, leading to bronchodilation and improved airflow. Salmeterol is characterized by its prolonged duration of action, typically lasting up to 12 hours, which makes it suitable for maintenance therapy rather than acute relief. The substance is often administered via inhalation, allowing for targeted delivery to the lungs while minimizing systemic side effects. Salmeterol is generally well-tolerated, but potential side effects may include palpitations, tremors, and headaches. It is important to note that salmeterol should not be used as a rescue medication for acute asthma attacks; instead, it is used in conjunction with inhaled corticosteroids for better control of chronic symptoms. As with any medication, it is essential to follow prescribed guidelines and consult healthcare professionals for appropriate use.
Formula:C25H37NO4
InChI:InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2
InChI key:InChIKey=GIIZNNXWQWCKIB-UHFFFAOYSA-N
SMILES:C(CNCCCCCCOCCCCC1=CC=CC=C1)(O)C2=CC(CO)=C(O)C=C2
Synonyms:- 1,3-Benzenedimethanol, 4-hydroxy-α<sup>1</sup>-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-
- 2-(Hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
- 2-Hydroxymethyl-4-[1-hydroxy-2-[6-(4-phenyl-butoxy)-hexylamino]-ethyl]-phenol
- 4-Hydroxy-α<sup>1</sup>-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol
- Cgp 54103
- Gr 33343X
- Salmeterol
- 1,3-Benzenedimethanol, 4-hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-
- 1,3-Benzenedimethanol, 4-hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-, (±)-
- 4-Hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
Salmeterol Xinafoate
CAS:Formula:C25H37NO4·C11H8O3Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:603.76Salmeterol
CAS:Salmeterol (GR33343X) is a long-acting agonist of beta2-adrenergic receptor (beta 2AR) used for treatment ofasthma.Formula:C25H37NO4Purity:99.2% - 99.9%Color and Shape:SolidMolecular weight:415.57Salmeterol-d3 (3-hydroxy-methyl-d2; α-d1)
CAS:Purity:98 atom % DColor and Shape:White SolidMolecular weight:418.59Salmeterol 100 µg/mL in Acetonitrile
CAS:Formula:C25H37NO4Color and Shape:Single SolutionMolecular weight:415.57Salmeterol
CAS:Controlled Product<p>Salmeterol is a long-acting bronchodilator that binds to eosinophil cationic protein and decreases inflammation. It is used in combination with fluticasone for the treatment of asthma. Salmeterol also has anti-inflammatory properties, which may be due to its binding to the glucocorticoid receptor and inhibition of prostaglandin synthesis. The drug binds to sodium citrate and xinafoate in vitro and may have an effect on cardiac function. Salmeterol is available as the xinafoate salt, salmeterol xinafoate, which is a prodrug that is hydrolyzed in vivo to salmeterol. This drug binds to the glucocorticoid receptor, leading to decreased inflammation by inhibiting the production of prostaglandin E2 and leukotriene B4. Salmeterol also causes relaxation of bronchial smooth muscle cells by activating potassium channels associated with their membrane potentials</p>Formula:C25H37NO4Purity:Min. 95%Color and Shape:PowderMolecular weight:415.57 g/mol
